SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-008156
Filing Date
2022-03-30
Accepted
2022-03-30 16:06:07
Documents
75
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1545537
2 ex4-4.htm EX-4.4 7942
3 ex21-1.htm EX-21.1 4220
4 ex23-1.htm EX-23.1 4145
5 ex31-1.htm EX-31.1 9956
6 ex31-2.htm EX-31.2 9881
7 ex32-1.htm EX-32.1 6094
8 form10-k_001.jpg GRAPHIC 100212
  Complete submission text file 0001493152-22-008156.txt   7202632

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE pcsa-20211231.xsd EX-101.SCH 88563
10 XBRL CALCULATION FILE pcsa-20211231_cal.xml EX-101.CAL 66207
11 XBRL DEFINITION FILE pcsa-20211231_def.xml EX-101.DEF 272703
12 XBRL LABEL FILE pcsa-20211231_lab.xml EX-101.LAB 571502
13 XBRL PRESENTATION FILE pcsa-20211231_pre.xml EX-101.PRE 393793
69 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 807836
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39531 | Film No.: 22786430
SIC: 2834 Pharmaceutical Preparations